Balyasny Asset Management LLC Repligen Corp Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $13.2 Million - $16.1 Million	77,176 New	77,176 $14.2 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $7.24 Million - $9.3 Million	-46,957 Reduced 36.76%	80,772 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $20.5 Million - $27.9 Million	126,515 Added 10421.33%	127,729 $21.6 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $194,749 - $311,038	1,214 New	1,214 $227,000
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $310,290 - $496,572	-1,925 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $476,610 - $586,104	1,925 New	1,925 $510,000
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $10.9 Million - $18.2 Million	-56,185 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $15.7 Million - $21 Million	-94,823 Reduced 62.79%	56,185 $11.2 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $7.53 Million - $9.44 Million	41,740 Added 38.2%	151,008 $29.4 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $2.51 Million - $3.5 Million	-16,964 Reduced 13.44%	109,268 $20.9 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $5.24 Million - $6.76 Million	42,736 Added 51.18%	126,232 $18.6 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $4.49 Million - $6.69 Million	47,646 Added 132.9%	83,496 $10.3 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $3.05 Million - $3.91 Million	35,850 New	35,850 $3.46 Million
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $1.16 Million - $1.44 Million	-15,109 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $382,977 - $607,322	7,066 Added 87.85%	15,109 $1.3 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $525,851 - $667,815	-10,634 Reduced 56.94%	8,043 $475,000
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $901,352 - $1.29 Million	18,677 New	18,677 $985,000
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $2.7 Million - $3.4 Million	-57,622 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $2.03 Million - $2.71 Million	57,622 New	57,622 $2.71 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.17 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$990 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$781 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$251 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$220 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account